Rhythm Pharmaceuticals buy Guggenheim
Start price
06.08.25
/
50%
€77.50
Target price
06.08.26
€103.73
Performance (%)
7.74%
Price
15.08.25
€81.50
Summary
This prediction is currently active. With a performance of 7.74%, the BUY prediction by Guggenheim for Rhythm Pharmaceuticals is trending in the right direction. This prediction currently runs until 06.08.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Rhythm Pharmaceuticals | 5.844% |
| iShares Core DAX® | 0.648% |
| iShares Nasdaq 100 | -0.034% |
| iShares Nikkei 225® | 2.445% |
| iShares S&P 500 | 0.492% |
Comments by Guggenheim for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Guggenheim from $119.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Guggenheim for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€75.50
10.07.25
10.07.25
-
10.07.26
10.07.26
10.60%
15.08.25
15.08.25
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€46.40
21.10.24
21.10.24
€64.45
21.10.25
21.10.25
75.65%
15.08.25
15.08.25